Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

1714 with DOI

2 strong · 9 moderate · 6 weak

Compilations

32026-05-09T09:51:53.937Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

41last ruled 2026-06-04

0 awaiting a ruling

Issued documents

42026-10-19T20:33:13.528Z

notice · info card · emergency

Searches

173 with no results

queries and counts on the build

Claims checked

6049 supported

49 supported · 11 not

Correspondence

0received

consent field ships in Phase 4

Edges

208

derivations recorded for this entity

Complete over 17 sources, 3 compilations, and 41 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/mxipr/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-09-07srcPhencyclidine-Based New Psychoactive Substances
  3. 2026-09-07src1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
  4. 2026-09-07srcDesigner drugs: mechanism of action and adverse effects
  5. 2026-09-07srcEmerging new psychoactive ketamine analogues: patterns of use and health risks identified by the French Addictovigilance Network
  6. 2026-09-07srcFatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE)
  7. 2026-09-07srcMethoxpropamine (MXPr) in powder, urine and hair samples: Analytical characterization and metabolite identification of a new threat
  8. 2026-09-07srcDerivatives of methoxetamine and major methoxetamine metabolites potently block NMDA receptors
  9. 2026-09-07src2-Fluorodeschloroketamine consumption: About two deaths and a case of self-mutilation
  10. 2026-09-07srcA Fatal Case Involving N-Ethyldeschloroketamine (2-Oxo-PCE) and Venlafaxine
  11. 2026-09-07srcKetamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
  12. 2026-09-07srcIdentification of Three Arylcyclohexylamines (MXPr, MXiPr, and DMXE) in Illegal Products
  13. 2026-09-07srcThe ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor
  14. 2026-09-07srcIn Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry
  15. 2026-09-07srcChiral Separation and Determination of Enantiomer Elution Order of Novel Ketamine Derivatives Using CE-UV and HPLC-UV-ORD
  16. 2026-09-07srcMXIPr - Methoxisopropamine Test Report (Druglab - Bus 31/32, Marseille)
  17. 2026-09-07srcCommunity-aggregated experience reports on MXiPr subjective effects and dosage
  18. 2026-09-07srcChemistry:Methoxisopropamine - HandWiki
  19. 2026-09-04issueIssued emergency
  20. 2026-09-04issueIssued info_card
  21. 2026-09-04issueIssued notice
  22. 2026-06-04proposal39 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  23. 2026-06-04publicationPublication — backfill
  24. 2026-05-09revisionRevision 1
  25. 2026-05-09absenceSearched ClinicalTrials.gov for "MXiPr dissociative" — no results
  26. 2026-05-09absenceSearched PubMed for "MXiPr dissociative arylcyclohexylamine" — no results
  27. 2026-05-09absenceSearched PubChem for "MXiPr" — no results
  28. 2026-05-09genGeneration — pipeline-v5 · with 2 morepipeline-v5
  29. 2026-05-09rungeneration run
  30. 2026-05-09rungeneration run
  31. 2026-05-09rungeneration run

The same entries, as forms: six forms.